CORZ Has Major Upside Following Failed CRWV Takeover
Macquarie has upgraded Core Scientific (CORZ) from neutral to outperform, raising its price target to $34 after the failed merger with CoreWeave (CRWV). This outcome is perceived positively, granting Core Scientific more flexibility in leasing its power capacity to AI tenants. The failure of the merger, which faced shareholder opposition, is seen as pivotal in allowing Core Scientific to diversify its revenue. Analysts noted that the company’s portfolio includes 1.5 gigawatts of power capacity, with plans to sign new colocation customers by the end of the year. The bank Jefferies also emphasized this pivot, highlighting the opportunity to move away from dependence on CoreWeave. The positive market reaction saw Core Scientific shares rise by 4.5% in early trading, reflecting investor confidence in the firm's potential to grow its data center business and attract new tenants.
Source 🔗